In October I started a phase 1 trial of ipatasertib in combination with atezolizumab. This immunotherapy trial is designed for patients with
advanced solid tumours with PI3K pathway hyperactivation. Today I got the scan results after three cycles which show no tumour progression and no significant SE's. This is still very early stages but I will now push on with the trial and see how I react to the treatment. I have been told PSA is only one key marker ( it has risen since trial started) with scans and how I feel being equally important. I am now one year into my Pc journey.